The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
- PMID: 32304994
- PMCID: PMC7152924
- DOI: 10.1016/j.intimp.2020.106504
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
Abstract
Aim: To accumulate evidence that indicated the key role played by virus-triggered inflammation in the 2019-novel coronavirus disease (COVID-19) which emerged in Wuhan City and rapidly spread throughout China.
Methods: Age, neutrophil(NEU)-to-lymphocyte (LYM) ratio (NLR), lymphocyte-to-monocyte (MON) ratio, platelet-to-lymphocyte ratio (PLR), and C-reactive protein (CRP) of 93 patients with laboratory confirmed COVID-19 were investigated and compared. The receiver operating characteristic curve was applied to determine the thresholds for five bio-markers, and their prognostic values were assessed via the Kaplan-Meier curve and multivariate COX regression models.
Results: The median age was 46.4 years old, and 37cases were females. A total of 27.8% of patients had been to Wuhan, and 73.1% had contacted with people from Wuhan. Fever (83.8%) and cough (70.9%) were the two most common symptoms. Elevated NLR and age were significantly associated with illness severity. The binary logistic analysis identified elevated NLR (hazard risk [HR] 2.46, 95% confidence interval [CI] 1.98-4.57) and age (HR 2.52, 95% CI 1.65-4.83) as independent factors for poor clinical outcome of COVID-19. NLR exhibited the largest area under the curve at 0.841, with the highest specificity (63.6%) and sensitivity (88%).
Conclusions: Elevated age and NLR can be considered independent biomarkers for indicating poor clinical outcomes.
Keywords: Age; COVID-19; Neutrophil-to-lymphocyte ratio; Platelet-to-LYM ratio; Predictive.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declared that there is no conflict of interest.
Figures
Comment in
-
NLR, d-NLR and PLR can be affected by many factors.Int Immunopharmacol. 2021 Jan;90:107154. doi: 10.1016/j.intimp.2020.107154. Epub 2020 Nov 21. Int Immunopharmacol. 2021. PMID: 33234416 Free PMC article.
References
-
- Hui D.S., Azhar I.E., Madani T.A., Ntoumi F., Kock R., Dar O., Ippolito G., Mchugh T.D., Memish Z.A., Drosten C. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis.: IJID: Off. Publ. Int. Soc. Infect. Dis. 2019;2020(91):264–266. - PMC - PubMed
-
- World Health Organization . World Health Organization; Geneva: 2019. Clinical Management of Severe Acute Respiratory Infection When Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection is Suspected: Interim Guidance.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous